Type
Blood Testing
Biomarkers
7
Duration
10 min
Results
48 hours
Diabetes screening combining fasting glucose and glycated haemoglobin (HbA1c) — the two complementary markers for detecting and monitoring glucose metabolism disorders. At 220 CZK (~9 EUR), a focused and affordable screen for the most common metabolic disease worldwide.
This panel combines two complementary approaches to glucose assessment. Fasting plasma glucose provides a snapshot of current glycaemic status, with diagnostic thresholds of 7.0 mmol/L (126 mg/dL) for diabetes and 5.6-6.9 mmol/L for impaired fasting glucose (pre-diabetes). HbA1c measures the percentage of haemoglobin molecules that have undergone non-enzymatic glycation over the preceding 8-12 weeks, providing a time-averaged picture of glycaemic control that is unaffected by meal timing or day-to-day fluctuations. The World Health Organization and American Diabetes Association both accept HbA1c ≥ 6.5% (48 mmol/mol) as independently diagnostic of diabetes. Values between 5.7-6.4% (39-47 mmol/mol) define pre-diabetes — a high-risk state where lifestyle intervention (diet, exercise, weight loss) can reduce progression to overt diabetes by 58%, according to the Diabetes Prevention Program trial. Using both markers together provides greater diagnostic sensitivity than either alone. Approximately 30% of diabetes cases detected by HbA1c would be missed by fasting glucose alone, and vice versa. The combination is particularly valuable for detecting discordant results that suggest early or atypical presentations. For patients already diagnosed with diabetes, HbA1c is the primary tool for monitoring treatment effectiveness. European guidelines recommend a target below 7.0% for most adults. Each 1% reduction in HbA1c is associated with approximately 21% reduction in diabetes-related complications. Type 2 diabetes prevalence in the Czech Republic is estimated at 8-9% of the adult population, with a further 15-20% in pre-diabetic states. Early detection and intervention are cost-effective at population level and life-changing at individual level. At 220 CZK (~9 EUR), this focused diabetes screen is accessible for routine use. Blood draw and serum separation are included.
Key Details
- Biomarkers
- 2
- Results
- 2 days
- Fasting
- Required (glucose)
Who Is This For?
Diabetes screening, pre-diabetes detection, diabetes monitoring, metabolic health
What's Included
Preparation Required
Fasting for 12 hours required for accurate fasting glucose. HbA1c does not require fasting but is drawn in the same sample.
Panel Categories
Biomarkers Tested
7A byproduct of insulin production, released in equal amounts to insulin. C-peptide measures how much insulin your pancreas is producing, helping distinguish between type 1 and type 2 diabetes.
A hormone produced by the pancreas that helps to control blood glucose levels and plays a role in controlling the levels of carbohydrates and fats stored in the body.
If you have diabetes your body doesn't process glucose effectively.
Blood sugar — the body's primary energy source. Fasting glucose screens for diabetes and prediabetes. Chronically elevated glucose damages blood vessels and organs. Levels fluctuate with meals, stress, and physical activity.
Calculated score assessing insulin resistance based on fasting glucose and insulin levels.
Reflects your average blood sugar over the past 2–3 months by measuring the percentage of hemoglobin with attached glucose. HbA1c is the gold standard for diagnosing and monitoring diabetes, unaffected by daily fluctuations.
The hormone produced by the pancreas to regulate blood sugar. Elevated fasting insulin — even with normal glucose — is an early marker of insulin resistance, which precedes type 2 diabetes by years. Key biomarker in longevity medicine.
220 CZK all-inclusive (blood draw + serum separation included).
- Category
- Diagnostic
- Sample Type
- Blood (venous draw)
- Duration
- 10 min
- Results
- 48 hours